ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

Course On Human Research Protections Goes Online @ Cancer.Gov.

January 26, 2001

MSKCC oncologist settles insider trading case with SEC.

November 11, 2005

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014